Cannabidiol (CBD) and Mental Health: Therapeutic Uses, Cautions, and Endocannabinoid System Support

This episode, hosted by Dr. Dawn Elise Snipes, provides a research-based analysis of cannabidiol (CBD), distinguishing it from its psychoactive counterpart, THC. The presentation emphasizes CBD's non-euphoric nature while highlighting its extensive therapeutic potential as an anti-inflammatory, anticonvulsant, antioxidant, anxiolytic, neuroprotective, immunomodulatory, and antipsychotic agent. A core argument is the necessity of relying on scientific evidence for CBD's benefits, cautioning against unsubstantiated claims prevalent online. The discussion also introduces the endocannabinoid system (ECS) and its crucial role in regulating various bodily functions, suggesting that CBD's efficacy stems from its interaction with CB1 and CB2 receptors.

A significant nuance explored is CBD's biphasic nature, meaning its effects vary with concentration, similar to alcohol. A critical distinction is made regarding the lack of FDA standardization for CBD products, which leads to inconsistencies in quality, purity, and potency across different suppliers. This regulatory gap poses challenges for consistent dosing and efficacy. The episode also carefully differentiates between CBD products and medical marijuana, particularly in the context of legal and employment-related drug testing, stressing that a medical prescription for THC-containing products does not negate potential legal or professional consequences.

Practical insights include a strong recommendation for individuals to consult their doctors before using CBD, especially if they are on any other medications, due to CBD's extensive interactions with the CYP450 enzyme system. The podcast offers actionable advice for naturally supporting the endocannabinoid system through dietary choices, such as consuming omega-3 fatty acids (found in hemp, chia, walnuts, fatty fish), dark cocoa powder, beta-carotene-rich foods (black pepper, cinnamon, hops), echinacea, kava, black and green teas, lactobacillus acidophilus, DIM (from broccoli), and curcumin (from turmeric). These natural compounds are shown to either stimulate cannabinoid receptors or prevent the breakdown of endogenous cannabinoids.

The broader implications of CBD's therapeutic potential are contextualized within a holistic view of mental and physical health. Dr. Snipes connects mood symptoms to underlying pathologies such as gut dysfunction, HPA axis dysregulation, inflammation, sex hormone imbalances, and thyroid issues, suggesting CBD as a potential adjunct or alternative for individuals unresponsive to conventional treatments like antidepressants. The episode also touches upon CBD's role in managing specific conditions like Parkinson's disease, C. difficile infections, chronic pain, and even mitigating alcohol withdrawal symptoms, underscoring its diverse applications but always with the caveat of careful medical consultation and awareness of its complex interactions and regulatory landscape.

I really wanted to stick with good research-based information so you're gonna see a lot of citations in here I didn't want to just go to any old website and take any old claim.

CBD actually interacts with just about every drug out there so it's really really important that people if they're on any kind of medication OTC or prescription talked to their doctor before starting to ingest it.

CBD is the major non psychoactive component of cannabis sativa... it's not going people are not going to get high from CBD oil.

CBD is a biphasic drug and it has different effects on the body at different blood level concentrations kind of like alcohol does.

CBD is not standardized by the FDA so you're not going to get something like if you get zoloft or xanax or something from the pharmacy you know you're getting exactly that number of milligrams per pill or per dropper full or pull per whatever per dose.

When the gut is dysfunctional when the microbiome is out of whack in the gut it doesn't produce or get rid of byproducts from the production of neurotransmitters nearly as well and there's a direct connection via the vagus nerve of the gut and the brain.

Manipulating the endocannabinoid system by introducing external cannabinoids like CBD could be useful in treating a variety of medical ailments.

Any drug metabolized by the SI y p450 enzymes could potentially interact with cannabidiol.

THC encourages alcohol consumption... but cannabidiol actually antagonizes that receptor and decreases people's desire to consume alcohol.

In order to produce the proper amount of endogenous cannabinoids the body requires sufficient amounts of omega-3 fatty acids which are the precursor to the endogenous cannabinoids.

Even if something is prescribed by a doctor... that does not matter when it comes to employment related drug testing and other situations potentially legal oriented drug testing.